Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKesson
AstraZeneca
Merck
Harvard Business School
Colorcon
McKinsey

Last Updated: November 19, 2019

DrugPatentWatch Database Preview

Fougera Company Profile

See Plans and Pricing

« Back to Dashboard

Summary for Fougera
International Patents:59
US Patents:5
Tradenames:57
Ingredients:49
NDAs:121
Patent Litigation for Fougera: See patent lawsuits for Fougera

Drugs and US Patents for Fougera

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fougera Pharms AMCINONIDE amcinonide LOTION;TOPICAL 076329-001 Nov 6, 2002 RX No Yes   Start Trial   Start Trial
Fougera Pharms PAMINE FORTE methscopolamine bromide TABLET;ORAL 008848-002 Mar 25, 2003 DISCN No No   Start Trial   Start Trial
Fougera Pharms CLOBETASOL PROPIONATE clobetasol propionate SOLUTION;TOPICAL 075391-001 Feb 8, 1999 AT RX No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Fougera

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Fougera Pharms Inc VEREGEN sinecatechins OINTMENT;TOPICAL 021902-001 Oct 31, 2006 5,968,973   Start Trial
Fougera Pharms CUTIVATE fluticasone propionate OINTMENT;TOPICAL 019957-001 Dec 14, 1990 4,335,121*PED   Start Trial
Fougera Pharms ACLOVATE alclometasone dipropionate OINTMENT;TOPICAL 018702-001 Dec 14, 1982 4,124,707   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Paragraph IV (Patent) Challenges for FOUGERA drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Lotion 0.05% ➤ Subscribe 2008-07-28
➤ Subscribe Topical Gel 3% ➤ Subscribe 2009-12-16

Supplementary Protection Certificates for Fougera Drugs

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
1448186 12C0058 France   Start Trial PRODUCT NAME: EXTRAIT SEC RAFFINE DE FEUILLE DE THE VERT (CAMELLIA SINENSIS (L.) O. KUNTZE) QUANTIFIE EN GALLATE D'(-)-EPIGALLOCATECHINE; NAT. REGISTRATION NO/DATE: NL41799 20120625; FIRST REGISTRATION: DE - 73186.00.00 20090831
1519731 92269 Luxembourg   Start Trial PRODUCT NAME: AZELASTINE,OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELUICI,ET UN ESTER PHARMACEUTIQUEMENT ACCEPTABLE DE FLUTICASONE
0145340 SPC/GB99/003 United Kingdom   Start Trial PRODUCT NAME: IMIQUIMOD; REGISTERED: UK EU/1/98/080/001 19980918
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
AstraZeneca
Johnson and Johnson
McKesson
Medtronic
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.